Our Product

OMIDRIA® (phenylephrine
and ketorolac intraocular
solution) 1% / 0.3%

OMIDRIA®

OMIDRIA is a first-of-kind drug approved both in the US and in Europe to prevent miosis in cataract surgery and to reduce postoperative pain. OMIDRIA has been shown to reduce complications, to prevent intraoperative floppy iris syndrome (IFIS) and to reduce the need for pupil-expansion devices and postoperative steroids.

OMIDRIA® is added to ophthalmic irrigating solution used during cataract surgery or intraocular lens replacement and is indicated for maintaining pupil size by preventing intraoperative miosis and reducing postoperative ocular pain.

IMPORTANT SAFETY INFORMATION

OMIDRIA must be added to irrigating solution prior to intraocular use.

OMIDRIA is contraindicated in patients with a known hypersensitivity to any of its ingredients.

Systemic exposure of phenylephrine may cause elevations in blood pressure.

Use OMIDRIA with caution in individuals who have previously exhibited sensitivities to acetylsalicylic acid, phenylacetic acid derivatives, and other nonsteroidal anti-inflammatory drugs (NSAIDs), or have a past medical history of asthma.

We use cookies to ensure our website works properly and to collect statistics about users in order for us to improve the website. If you continue to browse this site, you will accept our use of cookies. For more information, please read our
Privacy Policy.

Agree

You are now leaving Omeros.com

Omeros makes no representation as to the accuracy of the information on sites we do not own or control and does not recommend or endorse content on any third-party websites. Your use of a third-party website is at your own risk and subject to the terms and conditions of that site.